Evolution and clinical importance of fibrosis in HCM

JACC: Cardiovascular Imaging

Volumn 4, Issue 11, 2011, Pages 1221-1223

  Quarta, Giovanni ^a   Grasso, Agata ^a   Pasquale, Ferdinando ^a   Flett, Andrew S ^a   Sado, Daniel M ^a   Bonini, Elena ^a   Ariti, Cono ^a   Prasad, Sanjay K ^a   Elliott, Perry M ^a   Moon, James C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FOLLOW UP; GENE MUTATION; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; LATE GADOLINIUM ENHANCEMENT TECHNIQUE; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; FIBROSIS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 81255166641     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.04.023     Document Type: Letter

References (5)

1. B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713 (Pubitemid 37383745)
2. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, and D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567 (Pubitemid 36543376)
3. R. O'Hanlon, A. Grasso, and M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
4. A.S. Flett, J. Hasleton, and C. Cook Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance J Am Coll Cardiol Img 4 2011 150 156
5. N. Tsybouleva, L. Zhang, and S. Chen Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy Circulation 109 2004 1284 1291 (Pubitemid 38372788)